Related references
Note: Only part of the references are listed.Pharmacological Modulation of the Wnt/β-Catenin Pathway Inhibits Proliferation and Promotes Differentiation of Long-Lived Memory CD4+ T Cells in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques
M. Mavigner et al.
JOURNAL OF VIROLOGY (2020)
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity
Mariya B. Shapiro et al.
NATURE COMMUNICATIONS (2020)
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Marina Caskey et al.
NATURE MEDICINE (2019)
Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs
Ivan Sadowski et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Neutralizing antibodies for HIV-1 prevention
Boris Julg et al.
CURRENT OPINION IN HIV AND AIDS (2019)
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
Mansi Saxena et al.
FRONTIERS IN IMMUNOLOGY (2019)
Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform
Eytan Herzig et al.
CELL (2019)
The potential of engineered antibodies for HIV-1 therapy and cure
Marloes Grobben et al.
CURRENT OPINION IN VIROLOGY (2019)
TLR7 agonist administration to SIV-infected macaques receiving early initiated cART does not induce plasma viremia
Gregory Q. Del Prete et al.
JCI INSIGHT (2019)
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment
Amy L. Ellis-Connell et al.
JOURNAL OF VIROLOGY (2018)
HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine
Erin P. McGuire et al.
JOURNAL OF VIROLOGY (2018)
Rapid decline of HIV-1 DNA and RNA in infants starting very early antiretroviral therapy may pose a diagnostic challenge
Kirsten A. Veldsman et al.
AIDS (2018)
TLR agonist combinations that stimulate Th type I polarizing responses from human neonates
Naveen Surendran et al.
INNATE IMMUNITY (2018)
Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques
Maud Mavigner et al.
JOURNAL OF VIROLOGY (2018)
TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy
So-Yon Lim et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection
Yehuda Z. Cohen et al.
CURRENT OPINION IN HIV AND AIDS (2018)
Therapeutic HIV-1 vaccine: time for immunomodulation and combinatorial strategies
Nabila Seddiki et al.
CURRENT OPINION IN HIV AND AIDS (2018)
Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection
Paul Munson et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Quarter Century of Anti-HIV CAR T Cells
Thor A. Wagner
CURRENT HIV/AIDS REPORTS (2018)
Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques
Bonnie Phillips et al.
JOURNAL OF VIROLOGY (2018)
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Pilar Mendoza et al.
NATURE (2018)
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
Yotam Bar-On et al.
NATURE MEDICINE (2018)
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Matthew S. Parsons et al.
RETROVIROLOGY (2018)
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
Erica N. Borducchi et al.
NATURE (2018)
Antibody-mediated prevention and treatment of HIV-1 infection
Henning Gruell et al.
RETROVIROLOGY (2018)
The human IL-15 superagonist ALT-803 directs SIV-specific CD8(+) T cells into B-cell follicles
Gabriela M. Webb et al.
BLOOD ADVANCES (2018)
Dual TLR2 and TLR7 agonists as HIV latency-reversing agents
Amanda B. Macedo et al.
JCI INSIGHT (2018)
Use of broadly neutralizing antibodies for HIV-1 prevention
Amarendra Pegu et al.
IMMUNOLOGICAL REVIEWS (2017)
Role of HIV-specific CD8+ T cells in pediatric HIV cure strategies after widespread early viral escape
Ellen M. Leitman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
Angela Tsai et al.
JOURNAL OF VIROLOGY (2017)
Early antibody therapy can induce long-lasting immunity to SHIV
Yoshiaki Nishimura et al.
NATURE (2017)
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Marina Caskey et al.
NATURE MEDICINE (2017)
Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation
Linda Barlow-Mosha et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2017)
Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection
Kaitlin Rainwater-Lovett et al.
PLOS ONE (2017)
Anti-proliferative therapy for HIV cure: a compound interest approach
Daniel B. Reeves et al.
SCIENTIFIC REPORTS (2017)
Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection
Priyanka Uprety et al.
CLINICAL INFECTIOUS DISEASES (2017)
HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant
Cassandra A. Simonich et al.
CELL (2016)
Inhibition of Heat Shock Protein 90 Prevents HIV Rebound
Pheroze Joshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Towards HIV-1 remission: potential roles for broadly neutralizing antibodies
Ariel Halper-Stromberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
Erica N. Borducchi et al.
NATURE (2016)
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Johannes F. Scheid et al.
NATURE (2016)
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques
Ann J. Hessell et al.
NATURE MEDICINE (2016)
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
Till Schoofs et al.
SCIENCE (2016)
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Ching-Lan Lu et al.
SCIENCE (2016)
Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection
Maximilian Muenchhoff et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Elimination of HIV-1-infected cells by broadly neutralizing antibodies
Timothee Bruel et al.
NATURE COMMUNICATIONS (2016)
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
R. Brad Jones et al.
PLOS PATHOGENS (2016)
Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants
Margaret McManus et al.
PLOS ONE (2016)
Paediatric HIV infection: the potential for cure
Philip J. Goulder et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Passively Acquired Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity in HIV-Infected Infants Is Associated with Reduced Mortality
Caitlin Milligan et al.
CELL HOST & MICROBE (2015)
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
J. E. Ledgerwood et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy
Susanne von Stockenstrom et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice
Kieran Seay et al.
JOURNAL OF VIROLOGY (2015)
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Kai Deng et al.
NATURE (2015)
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice
Alonso Heredia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Regulation of T cells by mTOR: the known knowns and the known unknowns
Kristen N. Pollizzi et al.
TRENDS IN IMMUNOLOGY (2015)
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study
Cristina Mussini et al.
LANCET HIV (2015)
Infant HIV Type 1 gp120 Vaccination Elicits Robust and Durable Anti-V1V2 Immunoglobulin G Responses and Only Rare Envelope-Specific Immunoglobulin A Responses
Genevieve G. Fouda et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV
Florence M. Momplaisir et al.
PLOS ONE (2015)
Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset
Livio Azzoni et al.
PLOS ONE (2015)
Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
Ariel Halper-Stromberg et al.
CELL (2014)
Immune responses in neonates
Saleem Basha et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
CD4+ T Cells from Human Neonates and Infants Are Poised Spontaneously To Run a Nonclassical IL-4 Program
Katrin Hebel et al.
JOURNAL OF IMMUNOLOGY (2014)
HIV Type 1 (HIV-1) Proviral Reservoirs Decay Continuously Under Sustained Virologic Control in HIV-1-Infected Children Who Received Early Treatment
Katherine Luzuriaga et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Analysis of HLA A☆02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial
Andrew J. Gartland et al.
JOURNAL OF VIROLOGY (2014)
Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion
Evan Gomes-Giacoia et al.
PLOS ONE (2014)
Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir
Tae-Wook Chun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania
Matilda Ngarina et al.
BMC PUBLIC HEALTH (2013)
Immune activation and HIV persistence: implications for curative approaches to HIV infection
Nichole R. Klatt et al.
IMMUNOLOGICAL REVIEWS (2013)
Immunology of pediatric HIV infection
Nicole H. Tobin et al.
IMMUNOLOGICAL REVIEWS (2013)
An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells
Thor A. Wagner et al.
JOURNAL OF VIROLOGY (2013)
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Masashi Shingai et al.
NATURE (2013)
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Dan H. Barouch et al.
NATURE (2013)
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
Deborah Persaud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
Joshua A. Horwitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Metabolic complications and treatment of perinatally HIV-infected children and adolescents
Linda Barlow-Mosha et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2013)
Memory CD4+CCR5+ T cells are abundantly present in the gut of newborn infants to facilitate mother-to-child transmission of HIV-1
Madeleine J. Bunders et al.
BLOOD (2012)
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
Florian Klein et al.
NATURE (2012)
Risk of triple-class virological failure in children with HIV: a retrospective cohort study
Hannah Castro et al.
LANCET (2011)
Key factors in mTOR regulation
Xiaochun Bai et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children
K. BROLIDEN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
The Virologic and Immunologic Effects of Cyclosporine as an Adjunct to Antiretroviral Therapy in Patients Treated during Acute and Early HIV-1 Infection
Martin Markowitz et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Fetal and Adult Hematopoietic Stem Cells Give Rise to Distinct T Cell Lineages in Humans
Jeff E. Mold et al.
SCIENCE (2010)
First Report on a Series of HIV Patients Undergoing Rapamycin Monotherapy After Liver Transplantation
Fabrizio Di Benedetto et al.
TRANSPLANTATION (2010)
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
Irini Sereti et al.
BLOOD (2009)
Neonatal Innate TLR-Mediated Responses Are Distinct from Those of Adults
Tobias R. Kollmann et al.
JOURNAL OF IMMUNOLOGY (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Interleukin-2 Therapy in Patients with HIV Infection
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants.
Avy Violari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: Results of Pediatric AIDS Clinical Trials Study 402
Savita Pahwa et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Immunosuppressive drugs as an adjuvant to HIV treatment
E Fumero et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active Antiretroviral therapy for patients with chronic HIV infection -: A randomized pilot study
F García et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion
HM Lederman et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Breast milk and HIV-1: vector of transmission or vehicle of protection?
AP Kourtis et al.
LANCET INFECTIOUS DISEASES (2003)
The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication
J Roy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine
EJ McFarland et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-Infected women
CK Cunningham et al.
CLINICAL INFECTIOUS DISEASES (2001)
Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo
AG Chapuis et al.
NATURE MEDICINE (2000)
Share Paper
